Publications by authors named "Roland Mory"

Claim this Profile
3
3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 Inhibitors.
Emmanuel Pinard, Daniela Alberati, Ruben Alvarez-Sanchez, Virginie Brom, Serge Burner, Roland Mory

ACS Med Chem Lett· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia.
Daniela Alberati, Jean-Luc Moreau, Judith Lengyel, Nicole Hauser, Roland Mory

Neuropharmacology· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity.
Florent G Revel, Jean-Luc Moreau, Raul R Gainetdinov, Amyaouch Bradaia, Tatyana D Sotnikova, Roland Mory

Proc Natl Acad Sci U S A· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological evaluation of a novel assay for detecting glycine transporter 1 inhibitors and their antipsychotic potential.
Daniela Alberati, Jean-Luc Moreau, Roland Mory, Emmanuel Pinard, Joseph G Wettstein

Pharmacol Biochem Behav· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of benzoylisoindolines as a novel class of potent, selective and orally active GlyT1 inhibitors.
Emmanuel Pinard, Daniela Alberati, Markus Bender, Edilio Borroni, Virginie Brom, Roland Mory

Bioorg Med Chem Lett· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective GlyT1 inhibitors: discovery of [4-(3-fluoro-5-trifluoromethylpyridin-2-yl)piperazin-1-yl][5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methylethoxy)phenyl]methanone (RG1678), a promising novel medicine to treat schizophrenia.
Emmanuel Pinard, Alexander Alanine, Daniela Alberati, Markus Bender, Edilio Borroni, Roland Mory

J Med Chem· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia.
Gwenaëlle Le Pen, Laurent Gaudet, Patrick Mortas, Roland Mory, Jean-Luc Moreau

Psychopharmacology (Berl)· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis